DIVISLAB.NS Profit & Loss
Divi's Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:45
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹77.68 Bn | ₹78.45 Bn | ₹93.60 Bn | ₹105.60 Bn | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹3.45 Bn | ₹3.39 Bn | ₹3.52 Bn | ₹5.07 Bn | OtherIncome |
| Total Income | ₹81.12 Bn | ₹81.84 Bn | ₹97.12 Bn | ₹110.67 Bn | Income |
| Cost of Materials Consumed | ₹30.08 Bn | ₹32.32 Bn | ₹38.21 Bn | ₹43.78 Bn | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹0.22 Bn | ₹0.06 Bn | ₹0.00 Bn | ₹0.00 Bn | PurchasesOfStockInTrade |
| Changes in Inventories | ₹0.23 Bn | ₹-1.09 Bn | ₹-0.96 Bn | ₹-2.85 Bn | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹9.75 Bn | ₹10.94 Bn | ₹12.43 Bn | ₹14.42 Bn | EmployeeBenefitExpense |
| Finance Costs | ₹0.01 Bn | ₹0.03 Bn | ₹0.02 Bn | ₹0.23 Bn | FinanceCosts |
| Depreciation and Amortisation | ₹3.43 Bn | ₹3.78 Bn | ₹4.02 Bn | ₹4.63 Bn | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹13.71 Bn | ₹14.17 Bn | ₹14.24 Bn | ₹15.84 Bn | OtherExpenses |
| Total Expenses | ₹57.44 Bn | ₹60.21 Bn | ₹67.96 Bn | ₹76.05 Bn | Expenses |
| Profit Before Exceptional Items and Tax | ₹23.69 Bn | ₹21.63 Bn | ₹29.16 Bn | ₹34.62 Bn | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹-0.74 Bn | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹23.69 Bn | ₹21.63 Bn | ₹29.16 Bn | ₹33.88 Bn | ProfitBeforeTax |
| Tax Expense | ₹5.45 Bn | ₹5.63 Bn | ₹7.25 Bn | ₹8.20 Bn | TaxExpense |
| Net Profit (incl. minority interest) | ₹18.23 Bn | ₹16.00 Bn | ₹21.91 Bn | ₹25.68 Bn | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹18.23 Bn | ₹16.00 Bn | ₹21.91 Bn | ₹25.68 Bn | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹68.69 | ₹60.27 | ₹82.53 | ₹96.75 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹68.69 | ₹60.27 | ₹82.53 | ₹96.75 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from DIVISLAB.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).